«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

27卷

期数:

2021年03期

页码:

274-278

栏目:

技术与方法

出版日期:

2021-05-30

文章信息/Info

Title:

Expression and significance of GTSE1 gene in lung adenocarcinoma based on TCGA database

文章编号:

1006-8147(2021)03-0274-05

作者:

高周勇; 张文成; 王广舜

天津医科大学宝坻临床医学院肿瘤科，天津 301800

Author(s):

GAO Zhou-yong; ZHANG Wen-cheng; WANG Guang-shun

Department of Oncology，Baodi Clinical Medical College, Tianjin Medical University, Tianjin 301800，China

关键词:

肺腺癌; TCGA数据库; GTSE1

Keywords:

lung adenocarcinoma; TCGA database; GTSE1

分类号:

R734.2

DOI:

-

文献标志码:

A

摘要:

目的：探究G2/S期表达蛋白1（G2 and S phase-expressed protein1，GTSE1）在肺腺癌中的表达情况以及对预后的影响。方法：从癌症基因组图谱（TCGA）数据库中下载肺腺癌患者表达谱数据以及临床信息资料，分析GTSE1表达水平与临床指标信息之间的相关性及对预后的影响，并用Cox比例风险回归模型分析影响患者预后的因素。采用免疫组化检测14例肺腺癌肿瘤组织和13例癌旁组织中GTSE1表达水平。采用基因集富集分析方法（GSEA）预测GTSE1在肺腺癌中可能参与并调控的相关通路。结果：在TCGA数据中，在肿瘤组织样本中GTSE1基因表达情况明显高于正常组织（t=18.165，P<0.05），且表达水平与肿瘤分级（?字2=17.543，P=0.001）、T（?字2=8.825，P=0.032）和N分期（?字2=12.138，P=0.001）之间有显著相关，GTSE1高表达患者的总生存期显著低于GTSE1低表达的患者（?字2=22.663，P<0.05），单因素Cox分析提示肿瘤分级（HR=1.56，95%CI：1.33～1.83）、TNM分期（T：HR=1.60，95%CI：1.31～1.95；N：HR=1.70，95%CI：1.40～2.06；M：HR=1.83，95%CI：1.03～3.25）和GTSE1表达水平（HR=2.32，95%CI：1.62～3.30）可影响患者的总生存期（均P<0.05）。多因素Cox分析提示T分期（HR=1.646，95%CI：1.038～2.610，P=0.034）和GTSE1的表达水平（HR=1.830，95%CI：1.269～2.637，P<0.05）是影响肺腺癌患者总生存期的独立危险因素。GTSE1基因高表达的样本在细胞周期以及p53信号通路等9个通路基因集中富集（P<0.05，FDR<0.01）。结论：GTSE1在肺腺癌患者肿瘤组织中显著高表达，是肺腺癌患者的独立预后因素。

Abstract:

Objective: To explore the expression of G2 and S phase-expressed protein 1（GTSE1） in lung adenocarcinoma and its effect on prognosis. Methods: The expression profile data and clinical information of patients with lung adenocarcinoma were downloaded from the Cancer Genome Atlas（TCGA） database to analyze the correlation between GTSE1 expression and clinical indicator information and its influence on prognosis, and Cox proportional hazard regression model was used to analyze the factors affecting the prognosis of patients. Immunohistochemistry was used to detect GTSE1 expression in 14 lung adenocarcinoma tumor tissues and 13 adjacent tissues. Gene set enrichment analysis（GSEA） was used to predict the relevant pathways that GTSE1 might participate in and regulate lung adenocarcinoma. Results: In the TCGA database, GTSE1 gene expression in tumor tissue samples was obviously higher than that of normal tissue （t=18.165，P<0.01）, and the expression and tumor grade（?字2=17.543，P=0.001）, T（?字2=8.825，P=0.032） and N stage（?字2=12.138，P=0.001） had a significant correlation. The overall survival of patients with high expression of GTSE1 was significantly lower than that of patients with low expression of GTSE1（?字2=22.663，P<0.05）. Single factor analysis of Cox suggested tumor grade（HR=1.56，95%CI:1.33～1.83），TNM staging（T：HR=1.60，95%CI：1.31～1.95；N: HR=1.70，95%CI：1.40～2.06；M：HR=1.83，95%CI：1.03～3.25） and GTSE1 expression（HR=2.32, 95%CI：1.62～3.30） affected the patient′s overall survival（all P<0.05）. Multi-factors Cox analysis indicated that T stage （HR=1.646，95%CI：1.038～2.610，P=0.034） and GTSE1 expression（HR=1.830，95%CI：1.269～2.637，P<0.05） were independent risk factors for overall survival of patients with lung adenocarcinoma. The samples with high GTSE1 gene expression were concentrated in 9 pathway genes including cell cycle and p53 signaling pathway（P<0.05，FDR<0.01）. Conclusion：GTSE1 is highly expressed in the tumor tissues of patients with lung adenocarcinoma, and is an independent prognostic factor for patients with lung adenocarcinoma.

参考文献/References:

[1] Lei X，Du L，Zhang P，et al. Knockdown GTSE1 enhances radiosensitivity in non-small-cell lung cancer through DNA damage repair pathway[J]. J Cell Mol Med，2020，24（9）：5162
[2] Wang L，Ma Q，Yao R，et al. Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer[J]. Int Immunopharmacol，2020，79：106088
[3] Osmani L，Askin F，Gabrielson E，et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma （NSCLC）： moving from targeted therapy to immunotherapy[J]. Semin Cancer Biol，2018，52（Pt 1）：103
[4] Monte M，Benetti R，Buscemi G，et al. The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function[J]. J Biol Chem，2003，278（32）：30356
[5] Collavin L，Monte M，Verardo R，et al. Cell-cycle regulation of the p53-inducible gene B99[J]. FEBS Lett，2000，481（1）：57
[6] Monte M，Benetti R，Collavin L，et al. hGTSE-1 expression stimulates cytoplasmic localization of p53[J]. J Biol Chem，2004，279（12）：11744
[7] Bendre S，Rondelet A，Hall C，et al. GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK[J]. J Cell Biol，2016，215（5）：631
[8] Wu X，Wang H，Lian Y，et al. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis[J]. Sci Rep，2017，7（1）：5129
[9] Subhash V V，Tan S H，Tan W L，et al. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells[J]. BMC Cancer，2015，15：550
[10] Stelitano D，Peche L Y，Dalla E，et al. GTSE1：a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models[J]. Oncotarget，2017，8（40）：67422
[11] Lin F，Xie Y J，Zhang X K，et al. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner[J]. J Exp Clin Cancer Res，2019，38（1）：152
[12] Guo L，Zhang S，Zhang B，et al. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells[J]. Cell Biol Toxicol，2016，32（4）：263
[13] Liu A，Zeng S，Lu X，et al. Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation，migration，and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer[J]. Int J Biol Macromol，2019，123：322
[14] Xu T，Ma M，Chi Z，et al. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis[J]. Cancer Sci，2018，109（6）：1787
[15] Short B. GTSE1 leads cancer cells into CIN[J]. J Cell Biol，2016， 215（5）：593
[16] Liu X S，Li H，Song B，et al. Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery[J]. EMBO Rep，2010，11（8）：626

相似文献/References:

[1]林高阳,徐 克.氯化锂调控人肺腺癌A549细胞增殖侵袭转移的体外研究[J].天津医科大学学报,2015,21(01):9.
　LIN Gao-yang,XU Ke.Investigation of the effect of lithium chloride on proliferation and metastasis potential of human lung adenocarcinoma A549 cells in vitro[J].Journal of Tianjin Medical University,2015,21(03):9.
[2]赵青春,韦 森,张洪兵,等.分析第6版和第7版TNM分期在肺腺癌患者中的差异[J].天津医科大学学报,2015,21(05):432.
[3]陈赛鹏,王嘉南,王 林,等.基于TCGA数据库分析甲基化促进精原细胞瘤进程的作用机制[J].天津医科大学学报,2019,25(05):463.
　CHEN Sai-peng,WANG Jia-nan,WANG Lin,et al.Integrated analysis of the mechanism of methylation promoting the progress of seminomas based on the TCGA database[J].Journal of Tianjin Medical University,2019,25(03):463.
[4]王凤松,朱刘洋,白易,等.基于肿瘤突变负荷构建肝细胞癌风险评分预后模型[J].天津医科大学学报,2022,28(01):20.
　WANG Feng-song,ZHU Liu-yang,BAI Yi,et al.Identification of a risk score prognostic model of hepatocellular carcinoma based on tumor mutation burden[J].Journal of Tianjin Medical University,2022,28(03):20.
[5]李世雄,耿华,徐美林.肿瘤微环境中免疫与基质细胞相关基因在肺腺癌中的预后价值[J].天津医科大学学报,2022,28(01):47.
　LI Shi-xiong,GENG Hua,XU Mei-lin.Prognostic value of immune and stromal cell-related genes in tumor microenvironment in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(03):47.
[6]骆源,徐启飞,吕泽政,等.三维ResNet 网络预测肺腺癌结节亚型的效能及其 稳定性[J].天津医科大学学报,2022,28(03):295.
　LUO Yuan,XU Qi-fei,LYU Ze-zheng,et al.Efficacy and stability of 3D ResNet for predicting nodule subtypes in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(03):295.
[7]马梦楚,任媛媛,刘欣.肺腺癌细胞中PRDM5抑癌作用的分子机制初探[J].天津医科大学学报,2022,28(04):360.
　MA Meng-chu,REN Yuan-yuan,LIU Xin.Preliminary study on the molecular mechanism of PRDM5 suppression in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(03):360.

备注/Memo

备注/Memo:

作者简介 高周勇(1994-)，男，硕士在读，研究方向：肺癌蛋白质组学；
通信作者：王广舜，E-mail：wgs@bddhospital.com。

常用功能

更新日期/Last Update: 2021-05-30